Gala Renee D
- SEC CIK
- 0001607737
In the past year, 1 open-market sale filing worth $486.1K and no purchases.
Current role at each company
- JAZZ Jazz Pharmaceuticals plcPresident & CEOas of Sep 10, 2026
- DXCM Dexcom IncDirectoras of Jun 1, 2026
- GOSS Gossamer Bio, Inc.Directoras of Jun 9, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $486.1K
- 1 filing
- Net
- −$486.1K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Gala Renee D as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
JAZZ Jazz Pharmaceuticals plc
President & CEO3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 2026 (view filing)4:33 PM ET | Sep 8 | 2 days | Gala Renee DPresident & CEO | SSale | −2.00K | $243.03 | −$486.1K | −1.4%143.4K after | 10b5-1 |
| May 19, 2023 (view filing) | May 18 | 1 day | Gala Renee DEVP & Chief Financial Officer | SSale | −6.00K | $131.75 | −$790.5K | −14.3%36.0K after | |
| Dec 22, 2022 (view filing) | Dec 21 | 1 day | Gala Renee DEVP & Chief Financial Officer | SSale | −2.63K | $160.00 | −$421.6K | −7.5%32.6K after |